• 제목/요약/키워드: Primary liver cancer

검색결과 187건 처리시간 0.023초

Relationships between Self-Efficacy and Pap Smear Screening in Iranian Women

  • Majdfar, Zahra;Khodadost, Mahmoud;Majlesi, Freshteh;Rahimi, Abbas;Shams, Mohsen;Mohammadi, Gohar
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권sup3호
    • /
    • pp.263-268
    • /
    • 2016
  • Cervical cancer is the fourth common cancer among women worldwide. Pap smear screening has resulted in deceasing incidence of cervical cancer in developed countries but low uptake of Pap smear screening among women in developing countries is still a public health challenge. The aim of this cross-sectional study was to assess the relationship between self-efficacy and timely uptake of Pap smear among Iranian women. A total of 580 married women referred to primary health care centers covered administratively by Shahid Beheshti University of Medical Sciences in Tehran were administered a questionnaire by trained staff. Data were analyzed with SPSS (version 16) software, using univariate and multivariate logistic regression. The mean age for participants was $33.1{\pm}8.8years$. There was a significant association between self-efficacy and Pap smear screening (P<0.01). There was also a positive correlation between duration of marriage and husband's education with Pap smear uptake (P<0.01). In univariate analysis, there was a significant association between Pap smear uptake and level of selfefficacy (OR = 15.3 for intermediate and OR=7.4 for good level), duration of marriage (OR = 5.7 for 5-14 years and OR=10.4 for more than 15), age (OR =2.7 for 27-34 years and OR=7.4 for more than 35 years) and husband education level (OR=2.3 for more than 12 years of education). In multivariate analysis, significant associations persisted between Pap smear uptake and self-efficacy (OR = 23.8; 95% CI: 8.7, 65.5), duration of marriage (OR = 5.9; 95% CI: 2.8, 12.2), age (OR = 3.9; 95% CI: 1.2, 12.9) and husband's education (OR = 2.5; 95% CI: 2.0, 10.3). Efforts are needed to increase women's knowledge about cervical cancer and improve their self-efficacy and perceptions of the Pap smear screening in order to reduce cervical cancer incidence and mortality rates.

전신성 석회증을 동반한 부갑상선 암 1예 (A Case of Parathyroid Carcinoma with Systemic Calcification)

  • 김희식;이찬우;남상엽;박진철;윤지성;이재춘;원규장;조인호;김태년;이형우;현명수;이현우
    • Journal of Yeungnam Medical Science
    • /
    • 제14권2호
    • /
    • pp.459-466
    • /
    • 1997
  • 저자들은 원발성 부갑상선 기능 항진증과 함께 전신성 석회증을 동반한 부갑상선암 환자에서 부갑상선암 제거후 골 스캔상 폐와 위장의 전신성 석회화가 사라진 증례를 경험하여 보고하는 바이다.

  • PDF

Prospective Study on the Survival of HCC Patients Treated with Transcatheter Arterial Lipiodol Chemoembolization

  • Mao, Ying-Min;Luo, Zu-Yan;Li, Bo;Hu, Ting-Yang
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권3호
    • /
    • pp.1039-1042
    • /
    • 2012
  • Aim: Tanscatheter arterial embolization irrespective of with or without an anticancer agent and lipiodol has been controversial with regard to survival benefit. Therefore, we conducted a prospective study to analyze the effect of transcatheter arterial lipiodol chemoembolization (TACE) on the survival of HCC. Methods: A prospective study was conducted, and a total of 326 patients with primary liver cancer who were newly diagnosed were collected from January 2004 to January 2005 in Zhejiang Provincial People's Hospital of China. A univariate Cox's regression analysis was used to assess the survival of the HCC cases receiving TACE. Results: The duration of follow-up for the HCC patients treated with TACE ranged from 3 months to 60 months. For the overall patients, survival rate at 5 years was 42%. Both HBV Ag and HCV Ab positive patients showed significantly low survival rate at 5 years. The multivariate analysis revealed The IV TNM stage was related to an heavy increased risk of death of HCC patients, and Child C grade group showed a significant moderate increased risk. Conclusion: Our study showed TACE is associated with a better prognosis of HCC patients, and the HBV infection, TNM stage, Child-Pugh grade and number of TACE may influence the survival probability. Further TACE studies should be assess the quality of life of HCC patients, so as to provide more information for treatment of HCC.

Survival Rate of Intrahepatic Cholangiocarcinoma Patients after Surgical Treatment in Thailand

  • Sriputtha, Sudarat;Khuntikeo, Narong;Promthet, Supannee;Kamsaard, Supot
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권2호
    • /
    • pp.1107-1110
    • /
    • 2013
  • Intrahepatic cholangiocarcinoma (ICC), one of the primary liver cancers, is frequent in the northeastern part of Thailand. Surgical resection remains the best method of treatment, but patients suffering from ICC usually present at a late stage of the disease. Studies of survival and prognostic factors after surgery remain rare. The aim here was to evaluate the survival rate and factors affecting the survival of patients with intrahepatic cholangiocarcinoma after surgery. The study used a retrospective cohort design. The subjects were 73 consecutive patients with ICC, who were admitted for surgery to Srinagarind Hospital, Khon Kaen University, during the period 2005-2009. The censoring date was 31 December, 2011, data being evaluated using uni- and multivariate analyses. Postoperative survival analysis was performed by the Kaplan-Meier method, and the Cox proportional hazard model was used to identify independent prognostic factors. The total follow-up time was 99 person-years. The total number of deaths was 59, giving a mortality rate of 59 per 100 person-years. The cumulative 1-, 3-, and 5-year survival rates were 52.1%, 21.7%, and 11.2%, respectively. The median duration of survival after resection was 12.4 months. Univariate analysis revealed stage of disease, lymph node metastasis, histological type, histological grade and macroscopic classification to be statistically significant (p-value<0.05) prognostic factors. In the multivariate analysis, only macroscopic classification was statistically significant (p-value<0.05). In conclusion, macroscopic classification was the only independent factor found to be significantly associated with survival following surgical treatment of ICC.

사람 간암 세포주인 HepG2에 대한 인진호탕(茵陳蒿湯)의 항암 효과 (Herbal medicine In-Jin-Ho-Tang as a potential anti-cancer drug by induction of apoptosis in human hepatoma HepG2 cells.)

  • 윤현정;김병완;이창현;정재하;허숙경;박원환;박선동
    • 대한본초학회지
    • /
    • 제22권3호
    • /
    • pp.27-37
    • /
    • 2007
  • Objectives: Hepatocellular carcinoma is the most common primary malignant tumor of the liver worldwide. In-Jin-Ho-Tang(IJHT) has been used as a traditional Chinese herbal medicine since ancient time. and today it is widely applied as a medication for jaundice which is associated with inflammation in liver. In this study, I investigated whether methanol extract of IJHT induced HepG2 cancer cell death. Methods: Cytotoxic activity of IJHT on HepG2 cells was using XTT assay. Apoptosis induction by Ros A in HCT116 cells was verified by the induction of cleavage of poly ADP-ribose polymerase (PARP). and activation of caspase-3, -8 and -9. The release of cytochrome c from mitochondria to cytosol. the level of Bcl-2 and Bax and the expression of p53 and p21 were examined by western blotting analysis. Furthermore, MAPKs activation was analyzed by western blotting analysis. Results: IJHT induced apoptosis in HepG2 cells. And treatment of IJHT resulted in the release of cytochrome c into cytosol, decreased anti-apoptotic Bcl-2, and increased pri-apoptotic Bax expression. IJHT markedly inactivated extracellular signal-regulated kinase (ERK1/2), and activated p38 mitogen-activated protein (MAP) kinase. Sodium orthovanadate (SOV), a phosphatase inhibitor, to reverse IJHT-induced ERK1/2 inactivation and SB203580, a specific p38 MAP Kinase inhibitor efficiently blocked apoptosis of HepG2. Thus, IJHT induces apoptosis in HepG2 cells via MAP kinase modulation. Conclusion: These results indicated that IJHT has some potential for use as an anti-cancer agent.

  • PDF

Clinical Study of Hepatectomy Combined with Jianpi Huayu Therapy for Hepatocellular Carcinoma

  • Zhong, Chong;Li, Hui-Dong;Liu, Dong-Yang;Xu, Fa-Bin;Wu, Jian;Lin, Xue-Mei;Guo, Rong-Ping
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권14호
    • /
    • pp.5951-5957
    • /
    • 2014
  • Background: Traditional Chinese Medicine (TCM) possesses several advantages for treating patients with hepatocellular carcinoma (HCC). The theory of 'Jianpi Huayu Therapy' rooted from 'Jin Kui Yao Lue'is one of the most important therapies in this respect. This study was conducted to investigate the clinical effect and safety of hepatectomy combining with 'Jianpi Huayu Therapy' in the treatment of HCC. Materials and Methods: One hundred and twenty patients with HCC were randomized allocated into hepatectomy combined with 'Jianpi Huayu Therapy' group (treatment group, n=60) and hepatectomy alone group (control group, n=60). Disease- free survival (DFS) and overall survival (OS) were the primary end-points. Liver function at the end of one week after surgery, complications, average days of hospitalization as well as performance status (PS) at the end of one month post operation were also compared. Results: No significant differences existed between two groups on baseline analysis (p>0.05). No treatment related mortality occurred in either group. Post-operative complications were detected among 14 patients (23.3%) in the treatment group, and 12 (20.0%) in the control group (p=0.658). Alanine aminotransferase (ALT) at the end of one week after operation was lower in the treatment than control groups (p=0.042). No significant differences in other indexes of liver function were discovered between two groups. Average days of hospitalization reduced by 0.9 day in treatment group than in control (p=0.034). During follow-up, 104 patients (86.6%) developed recurrence. The rates of 1-, 3-, and 5-year DFS and median DFS for all patients were 77.4%, 26.3%, 9.0% and 25.6 months (range, 6.0~68.0), respectively (78.2%, 29.2%, 14.3% and 28.7 months for the 48 patients in the treatment group and 75.0%, 23.3%, 6.4%, and 22.6 months for the 56 patients in the control group (p=0.045)). 101 patients had died at the time of censor, with 1-, 3-, and 5-year overall survival rates and median survival for all patients of 97.5%, 76.4%, 40.5% and 51.2 months (range, 10.0~72.0), respectively (98.3%, 78.0%, 43.6% and 52.6 months, for treatment and 96.7%, 74.7%, 37.4%, and 49.8 months, for controls, respectively (p=0.048)). Conclusions: Hepatectomy combined with 'Jianpi Huayu therapy'was effective in the treatment of HCC, and reduced post-operative recurrence and metastasis and improved DFS and OS of HCC patients.

유도화학요법 및 국소 치료 후 원격전이를 보인 국소 진행성 두경부암 환자군의 임상 특징 및 위험인자에 관한 연구 (Clinical Features and the Risk Factors of Distant Metastasis in Locally Advanced Advanced Head and Neck Cancer Patients after Induction Chemotherapy Followed Locoregional Control Therapy)

  • 이혜원;백동훈;이경남;조은정;김효정;설영미;송무곤;최영진;신호진;정주섭;조군제
    • 대한두경부종양학회지
    • /
    • 제27권2호
    • /
    • pp.177-182
    • /
    • 2011
  • Backgrounds : Head and neck cancer is one of the most prevalent cancers in the world. It tends to remain localized at the primary site and regional lymph nodes, but if distant metastasis occurs, it has a poor prognosis. This study was performed to evaluate the prevalence of distant metastasis and to determine the risk factor in locally advanced head and neck cancer after induction chemotherapy followed locoregional control therapy. Methods : A retrospective review was performed in 420 patients with locally advanced head and neck cancer who treated with induction chemotherapy followed locoregional control therapy from January 2001 to December 2010. Among them, 31 patients who had distant metastasis as first relapse within 2 years after termination of therapy were analyzed for clinical features and the risk factors of distant metastasis. Results : The overall incidence of distant metastasis was 7.3%. The bone, lung, and liver were the most frequent metastatic organs. In univariate analysis, nodal stage, nasopharyngeal cancer, laryngeal cancer, G3/G4 neutropenia during induction chemotherapy, and concurrent chemoradiotherapy were the influencing factors for distant metastasis. In multivariate analysis, advanced N stage and nasopharynx were the risk factors of distant metastasis, and grade 3/4 neutropenia during induction chemotherapy was considered to decrease distant metastasis. Conclusion : This study suggests that the advanced N stage is the risk factor of distant metastasis and Grade 3/4 neutropenia during induction chemotherapy can be beneficial against distant metastasis in locally advanced head and neck cancer patients treated with induction chemotherapy followed locoregional control therapy.

간외 담관계암의 방사선치료와 온열치료의 병용요법 (External Radiation Therapy Combined with Hyperthermia in the Carcinoma of Extrahepatic Biliary System)

  • 배훈식
    • Radiation Oncology Journal
    • /
    • 제10권1호
    • /
    • pp.49-58
    • /
    • 1992
  • 1986년 1월부터 1990년 9월까지 7예의 간외담도계 암 환자를 대상으로 외부 방사선치료와 온열치료를 병행하였다. 7예중 3예는 간외담도암으로 이중 2예는 원발성 담도암 이었고 1예는 위암에서 담도주위로 전이된 암이었다. 7예중 나머지 4예는 담낭암으로 이중 2예는 담낭 절제후 국소적으로 재발된 암이었고 나머지 2예는 원발성 담낭암 이었다. 그리고 7예는 모두 선암으로 확인 되었다. 조사된 방사선의 양은 3000 cGy/2주 조사한 1예를 제외하고 6예에서는 $4500\~5040\;cGY/6\~7$주 조사되었다. 온열치료는 모든 환자에서 방사선치료후 30분 이내에 시행되었으며 방사선치료 기간동안 주 1회 내지 2회씩 총 4회에서 12회까지 시행되었다. 치료효과의 판정은 T-관 T-관 담도촬영술. PTC, 그리고 CT등의 소견으로 하였으며 7예중 6예($86\%$)에서 부분관해를 보였으며 완전관해는 없었다. 7예중 6예는 4개월에서 11개월 애내 사망하였으며 나머지 1예는 현재 11개월째 생존하고 있으나 치료부위 밖에서 국소전이가 관찰되었다. 그리고 7예환자의 정중생존기간은 7개월이었다. 사망환자 6예의 사망원인으로는 원발성 담도암환자 1예에서 폐혈증, 전이성 담도암환자에서 원격 전이, 나머지 4예에서는 원발병소의 진행이 확인되었다. 관찰기간이 짧았으나 모든 환자에서 치료에 잘 적응하였으며 간, 십이지장, 위내의 합병증은 없었고 전이성 담도암 환자에서 일과성 카보닐산혈증이 관찰되었다.

  • PDF

간 이식 예정 환자의 구강건강상태 및 치과치료 요구도에 관한 연구 (Oral Health Status and Dental Treatment Need of Liver Transplant Candidates)

  • 박태준;고홍섭
    • Journal of Oral Medicine and Pain
    • /
    • 제34권1호
    • /
    • pp.1-9
    • /
    • 2009
  • 간 이식은 진행성 간병변의 말기에 있는 환자나 간 대사 질환, 간암 등을 겪고 있는 환자들에게 최종적으로 행해지는 가장 효과적인 치료법이다. 간 이식 전후에는 타 장기의 이식수술 시와 마찬가지로 거부반응을 최소화하고 생존율을 높이기 위하여 면역억제요법을 시행하게 되며 이로 인해 면역력이 감소되어 전신 감염에 이환되기 쉬운 상태에 처하게 된다. 간 이식수술 전 치과적 처치의 일차적 목표는 간을 이식한 후 전신적인 감염의 원인이 될 수 있는 구강 감염요소를 원천적으로 제거하는 것이다. 술전 치과적 처치는 이식 후 감염 가능성을 줄여줌으로써 이식수술의 성공률을 향상시키므로 환자의 건강을 유지하는 데 있어서 구강검진을 비롯한 계속적인 치과적 관리는 중요한 의미를 갖는다. 본 연구에서는 간이식 수술을 예정으로 수술 전 구강검진을 위해 서울대학교 치과병원에 내원한 90명의 환자들의 의무기록에 근거하여 우식경험영구치지수와 구강위생의 정도, 전신질환 병력과 치과치료 요구도, 치과치료 요구도의 충족 정도, 치과병원 내원일과 간이식 수술 예정일과의 시간 간격 등에 대한 조사를 시행하여 다음과 같은 결론을 얻었다. 1. 환자군의 우식경험영구치지수를 분석한 결과 간이식 환자들의 DT는 2.68개, MT는 4.02개, FT는 3.42개, 그리고 DMFT index는 10.12개로 나타났다. 2. 환자군의 구강위생 상태를 조사한 결과 중등도 이상의 식편 압입이 20.0%로 나타났고, 중등도 이상의 치석을 가진 환자는 42.2%였으며 부종을 동반한 치은염증은 37.8%의 환자들에서 관찰되었다. 3. 환자군에게 필요한 치과치료요구도를 조사한 결과 치주치료를 가장 많이 필요로 하였고 그 다음으로 보존치료, 구강악안면외과적 치료의 순서였다. 4. 90명의 환자 중 간이식 예정일이 확정된 상태로 치과병원에 내원한 환자는 39명이었고 간이식 예정일과 치과병원에서의 구강검진일자와의 시간간격을 조사한 결과 간이식 예정일과 구강검진일자와의 시간간격이 2주 이하가 32.2%, 1주 이하가 20.0%로 나타났다. 이상의 결과로 보아, 간 이식수술 전 구강검진을 주소로 내원한 환자들은 이식수술 후 잠재적 감염원의 제거를 위해 해결이 필요한 뚜렷한 치과치료 요구도를 나타내고 있다. 하지만 간 이식수술 전 치과치료를 위한 충분한 시간이 주어지지 못하는 현실적 제약으로 인해 많은 환자들이 포괄적인 치과관리를 받지 못한 채 이식수술을 받고 있다. 따라서 간 이식수술 가능성이 있는 환자를 대상으로 조기 구강건진과 포괄적인 구강관리 프로그램에 대한 구체적인 지침과 협진 체계가 마련된다면 잠재적인 구강 감염원의 충분한 제거로 간 이식수술의 예후에 긍정적인 역할을 할 수 있을 것이다.

Huh7 간암세포에서 민들레 추출물의 상피간엽전환 억제를 통한 항전이 효과 (Anti-metastatic Effect of Taraxacum Officinale Water and Ethanol Extracts Through the Regulation of Epithelial-Mesenchymal Transition in Huh7 Cells)

  • 윤현서;안현;박충무
    • 대한통합의학회지
    • /
    • 제11권3호
    • /
    • pp.59-67
    • /
    • 2023
  • Purpose : Epithelial-to-mesenchymal transition (EMT) is recognized as an important cellular response in metastatic proceduresand characterized by loss of cellular polarity as well as gain of mesenchymal features, which enables migration and invasion. Hepatocellular carcinoma (HCC) is one of the most common primary carcinomas in the liver and exhibits a poor prognosis due to frequent extrahepatic metastasis. Taraxacum officinale has been used for a long time in oriental medicine because of its various pharmacological activitiessuch as anti-rheumatic, anti-inflammatory, antioxidative, and anticarcinogenic activities. In this study, the anti-metastatic activity of T. officinale water extract (TOWE) and ethanol extract (TOEE) was investigated through the regulation of EMT in the Huh7 cells. Methods : The effects of TOWE and TOEE on migratory and invasive activities were investigated by wound healing and in vitro invasion assays. Western blot analysis was also applied to analyze protein expression levels associated with EMT and their upstream transcription factors in Huh7 cells. Results : TOWE and TOEE treatment potently inhibited migration and invasion of Huh7 cells compared to the untreated group. Both extracts treatment inhibited protein expression levels of N-cadherin, matrix metalloproteinase (MMP)-9, and vimentin while E-cadherin was significantly accelerated. In addition, the activated status of transcription factors, Snail, nuclear factor (NF)-κ B, and zinc finger E-box binding homeobox (ZEB)1 was also inhibited with statistical significance. In comparison to both extracts, TOEE more potently attenuated migration, invasion, and EMT markers as well as their transcription factors in Huh7 cells than TOWE, which means that TOEE might possess more functional phytochemicals than TOWE. Conclusion : Consequently, TOWE and TOEEattenuated metastatic activity of hepatocellular carcinoma through the regulation of EMT markers and their transcription factors in Huh7 cells, which means that T. officinale might be a promising strategy for a chemopreventive agent against HCC metastasis.